Optimizing Patient Care in EGFR-Mutated NSCLC: AE Management and Supportive Care Strategies : Episode 3
Managing Dermatologic Toxicities with EGFR Targeted Therapies in NSCLC
Panelists discuss how dermatologic toxicities from EGFR-targeted therapies can be effectively managed through a comprehensive approach combining prophylactic measures, early interventions with oral antibiotics and topical treatments, and patient education about self-management strategies.
Video content above is prompted by the following:
- Let's discuss dermatologic toxicities associated with EGFR-targeted therapies. What's your approach to managing these adverse events?
- What prophylactic measures and early interventions have you found most effective in mitigating dermatologic toxicities?
- How do you utilize oral antibiotics, topical treatments (such as lotions or creams), and systemic medications in your management plan?
- How do you incorporate patient education and self-management techniques into your overall strategy?
Recent Videos
Related Content
